+16.3%
FIX vs MRNA
+787.6%
-771.3%
-53.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.8% | -7.0% | +4.2% | -2.7% |
| 7D | +17.0% | -4.2% | +21.2% | +17.1% |
| 30D | -30.6% | +7.0% | -37.6% | -30.6% |
| 3M | -35.0% | +263.4% | -298.4% | -35.6% |
| 6M | -44.0% | +334.3% | -378.2% | -47.6% |
| YTD | +21.1% | +684.5% | -663.4% | -4.8% |
| 1Y | +16.3% | +766.2% | -749.9% | -15.1% |
| All | +16.3% | +787.6% | -771.3% | -15.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling